Physician profile
Manuel Montalvo
NPI 1336464320
$3,014.83
in general payments reported to CMS, 2019-2025
16 companies · $540 in 2025
The $540 reported for 2025 was more than what 80% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $841 · 2020: $66.43 · 2021: $234 · 2022: $502 · 2023: $408 · 2024: $424 · 2025: $540.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,372.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,371.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,408.50 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $266.63 | 2019-2025 | Capvaxive |
| Astrazeneca Pharmaceuticals LP | $223.45 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $152.82 | 2022-2024 | Zeposia |
| Madrigal Pharmaceuticals | $145.93 | 2024-2025 | Rezdiffra, Resmetirom |
| Amgen INC. | $139.60 | 2022-2024 | Amjevita |
| Ipsen Biopharmaceuticals, INC | $125.00 | 2024 | Iqirvo |
| Pfizer Pharmaceuticals LLC | $125.00 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $100.58 | 2025 | Entyvio |
| Glaxosmithkline, LLC. | $96.56 | 2019 | |
| Janssen Pharmaceuticals, INC | $92.62 | 2019-2025 | Tremfya |
| Ferring Pharmaceuticals INC. | $62.53 | 2019-2020 | |
| Exact Sciences Corporation | $25.00 | 2024 | Cologuard Collection Kit |
| Intercept Pharmaceuticals, INC. | $24.75 | 2020 | |
| Pbg Puerto Rico LLC | $18.00 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $7.86 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Manuel Montalvo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.